Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions

Neuropathology

Volumn 35, Issue 1, 2015, Pages 37-43

  Honda, Hiroyuki ^a   Hamasaki, Hideomi ^a   Wakamiya, Tomihiro ^a   Koyama, Sachiko ^a   Suzuki, Satoshi O ^a   Fujii, Naoki ^b   Iwaki, Toru ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Omuta National Hospital   (Japan)

Author keywords

Amyotrophic lateral sclerosis; hnRNP; hnRNPA1; Motor neuron; TDP 43

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HNRNP A1; TDP-43 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE AGED; MOTONEURON; MUSCULAR DYSTROPHY; NERVE CELL; PRIORITY JOURNAL; RNA PROCESSING; SPINAL CORD; VERY ELDERLY; YOUNG ADULT; CELL INCLUSION; METABOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DNA-BINDING PROTEINS; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCULAR DYSTROPHIES; SPINAL CORD; YOUNG ADULT;

EID: 84920964406     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12153     Document Type: Article

References (22)

1. Neumann M, Sampathu DM, Kwong LK etal. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
2. Arai T, Hasegawa M, Akiyama H etal. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
3. Van Deerlin VM, Leverenz JB, Bekris LM etal. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008; 7: 409-416.
4. Sreedharan J, Blair IP, Tripathi VB etal. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 319: 1668-1672.
5. Kabashi E, Valdmanis PN, Dion P etal. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008; 40: 572-574.
6. King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012; 1462: 61-80.
7. Bekenstein U, Soreq H. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles. Mol Cell Neurosci 2013; 56: 436-446.
8. Donev R, Newall A, Thome J, Sheer D. A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms. Mol Psychiatry 2007; 12: 681-690.
9. Berson A, Barbash S, Shaltiel G etal. Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med 2012; 4: 730-742.
10. Kim HJ, Kim NC, Wang YD etal. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013; 495: 467-473.
11. Ayala YM, Pantano S, D'Ambrogio A etal. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 2005; 348: 575-588.
12. Neumann M, Igaz LM, Kwong LK etal. Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration. Acta Neuropathol 2007; 113: 543-548.
13. Kashima T, Rao N, David CJ, Manley JL. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. Hum Mol Genet 2007; 16: 3149-3159.
14. Sueoka E, Yukitake M, Iwanaga K, Sueoka N, Aihara T, Kuroda Y. Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients. Ann Neurol 2004; 56: 778-786.
15. Lee S, Xu L, Shin Y etal. A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease. J Neuroimmunol 2011; 235: 56-69.
16. Lee SM, Dunnavant FD, Jang H, Zunt J, Levin MC. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease. Neurosci Lett 2006; 401: 188-193.
17. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 2005; 280: 37572-37584.
18. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124 (Suppl): 96-107.
19. Mayeda A, Munroe SH, Xu RM, Krainer AR. Distinct functions of the closely related tandem RNA-recognition motifs of hnRNP A1. RNA 1998; 4: 1111-1123.
20. Siomi H, Dreyfuss G. A nuclear localization domain in the hnRNP A1 protein. J Cell Biol 1995; 129: 551-560.
21. Seelen M, Visser AE, Overste DJ etal. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging 2014; 35: 1956e9-1956.e11.
22. Ayala YM, De Conti L, Avendano-Vazquez SE etal. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 2011; 30: 277-288.